Relationship between helicobacter pylori infection and serum interleukin-18 in patients with carotid atherosclerosis

Helicobacter

Volumn 18, Issue 2, 2013, Pages 124-128

  Chen, Bao Feng ^a   Xu, Xin ^a   Deng, Yun ^a   Ma, Shao Chun ^a   Tang, Liang Qiu ^a   Zhang, She Bing ^a   Chen, Ze Fang ^a  

^a YUEBEI PEOPLE S HOSPITAL   (China)

Author keywords

Carotid atherosclerosis; Helicobacter pylori infection; Interleukin 18

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 18; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HELICOBACTER INFECTION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-18; MALE; MIDDLE AGED;

EID: 84875009438     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/hel.12014     Document Type: Article

References (32)

1. Laurila A, Bloigu A, Näyhä S, et al. Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis. 1999;142:207-10.
2. Kinjo K, Sato H, Sato H, et al. Prevalence of Helicobacter pylori infection and its link to coronary risk factors in Japanese patients with acute myocardial infarction. Circ J 2002;66:805-10.
3. Niemelä S, Karttunen T, Korhonen T, et al. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart 1996;75:573-5.
4. Elhage R, Jawien J, Rudling M, et al. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res 2003;59:234-40.
5. Mallat Z, Corbaz A, Scoazec A, et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001;104:1598-603.
6. Gerdes N, Sukhova GK, Libby P, et al. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 2002;195:245-57.
7. Chandrasekar B, Mummidi S, Valente AJ, et al. The pro-atherogenic cytokine interleukin-18 induces CXCL16 expression in rat aortic smooth muscle cells via MyD88, interleukin-1 receptor-associated kinase, tumor necrosis factor receptor-associated factor 6, c-Src, phosphatidylinositol 3-kinase, Akt, c-Jun N-terminal kinase, and activator protein-1 signaling. J Biol Chem 2005;280:26263-77.
8. Yamagami H, Kitagawa K, Hoshi T, et al. Associations of serum IL-18 levels with carotid intima-media thickness. Arterioscler Thromb Vasc Biol 2005;25:1458-62.
9. Blankenberg S, Tiret L, Bickel C, et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002;106:24-30.
10. Tomita T, Jackson AM, Hida N, et al. Expression of Interleukin-18, a Th1 cytokine, in human gastric mucosa is increased in Helicobacter pylori infection. J Infect Dis 2001;183:620-7.
11. Sakai K, Kita M, Sawai N, et al. Levels of interleukin-18 are markedly increased in Helicobacter pylori-infected gastric mucosa among patients with specific IL18 genotypes. J Infect Dis 2008;197:1752-61.
12. Bamford KB, Fan X, Crowe SE, et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 1998;114:482-92.
13. D'Elios MM, Manghetti M, De Carli M, et al. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 1997;158:962-7.
14. Okamura H, Tsutsi H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995;378:88-91.
15. Yamauchi K, Choi IJ, Lu H, et al. Regulation of IL-18 in Helicobacter pylori infection. J Immunol 2008;180:1207-16.
16. Sugimoto M, Ohno T, Graham DY, et al. Gastric mucosal interleukin-17 and -18 mRNA expression in Helicobacter pylori-induced Mongolian gerbils. Cancer Sci 2009;100:2152-9.
17. Grabczewska Z, Nartowicz E, Kubica J, et al. Endothelial function parameters in patients with unstable angina and infection with Helicobacter pylori and Chlamydia pneumoniae. Eur J Intern Med 2006;17:339-42.
18. Kaplan M, Yavuz SS, Cinar B, et al. Detection of Chlamydia pneumoniae and Helicobacter pylori in atherosclerotic plaques of carotid artery by polymerase chain reaction. Int J Infect Dis. 2006;10:116-23.
19. Ozdogru I, Kalay N, Dogan A, et al. The relationship between Helicobacter pylori IgG titre and coronary atherosclerosis. Acta Cardiol 2007;62:501-5.
20. Jia EZ, Zhao FJ, Hao B, et al. Helicobacter pylori infection is associated with decreased serum levels of high density lipoprotein, but not with the severity of coronary atherosclerosis. Lipids Health Dis 2009;8:59.
21. Blum A, Tamir S, Mualem K, et al. Endothelial dysfunction is reversible in Helicobacter pylori-positive subjects. Am J Med 2011;124:1171-4.
22. Moss SF, Legon S, Davies J, et al. Cytokine gene expression in Helicobacter pylori associated antral gastritis. Gut 1994;35:1567-70.
23. Crabtree JE, Shallcross TM, Heatley RV, et al. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991;32:1473-7.
24. Ishida Y, Suzuki K, Taki K, et al. Significant association between Helicobacter pylori infection and serum C-reactive protein. Int J Med Sci 2008;5:224-9.
25. Saribas S, Kocazeybek B, Aslan M, et al. Do procalcitonin and C-reactive protein levels have a place in the diagnosis and follow-up of Helicobacter pylori infections? J Med Microbiol 2004;7:639-44.
26. Kebapcilar L, Bilgir O, Cetinkaya E, et al. The effect of Helicobacter pylori eradication on macrophage migration inhibitory factor, C-reactive protein and fetuin-a levels. Clinics (Sao Paulo) 2010;65:799-802.
27. Cammarota G, Pasceri V, Gasbarrini A, et al. Helicobacter pylori is an aetiological factor for ischaemic heart disease: the case against. Dig Liver Dis 2000;32:65-8.
28. Realdi G, Dore MP, Fastame L. Extradigestive manifestations of Helicobacter pylori infection: fact and fiction. Dig Dis Sci 1999;44:229-36.
29. Abdelmouttaleb I, Danchin N, Ilardo C, et al. C-Reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J 1999;137:346-51.
30. Gasbarrini A, Franceschi F, Cammarota G, et al. Vascular and immunological disorders associated with Helicobacter pylori infection. Ital J Gastroenterol Hepatol 1998;30:115-8.
31. Stone AF, Mendall MA. Helicobacter pylori is an aetiological factor for ischaemic heart disease: the case in favour. Dig Liver Dis 2000;32:62-4.
32. Kim JH, Kim HY, Kim NY, et al. Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea. J Gastroenterol Hepatol 2001;16:969-75.